Natera and Eledon partner on kidney transplant Phase 3 trial
Go back to Natera and Eledon partner on kidney transplant Phase 3 trial| (NASDAQ: ELDN) | Delayed: 4.05 +0.19 (4.92%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.86 | 52 Week High | $ | |||
| Open | $3.88 | 52 Week Low | $ | |||
| Day High | $4.05 | P/E | N/A | |||
| Day Low | $3.81 | EPS | $ | |||
| Volume | 1,026,649 | |||||
| (NASDAQ: NTRA) | Delayed: 272.66 -0.23 (0.08%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $272.89 | 52 Week High | $13.80 | |||
| Open | $276.73 | 52 Week Low | $6.52 | |||
| Day High | $278.80 | P/E | N/A | |||
| Day Low | $271.23 | EPS | $0.00 | |||
| Volume | 954,566 | |||||
